MAPT and Alzheimer disease: Fifteen-month-old 3xTg-AD mice, which develop both Aβ and tau pathologies as they age [22], were treated for either 6 weeks (n = 8 per group) or 3 months with 300 mg/kg chow PLX5662 or vehicle (n = 10 per group).